High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy

HIV Medicine

Volumn 11, Issue 1, 2010, Pages 85-89

  Laurent, C ^a   Bourgeois, A ^b   Mpoudi Ngole E ^c   Kouanfack, C ^d   Ciaffi, L ^e   Nkoue N ^c   Mougnutou, R ^c   Calmy, A ^e   Koulla Shiro, S ^d   Ducos, J ^b   Delaporte, E ^b  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c Military Hospital   (Cameroon)

^d YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^e MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

Africa; Antiretroviral therapy; HBV; HCV; HIV

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIGEN; LAMIVUDINE; LIVER ENZYME; NEVIRAPINE; STAVUDINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CAMEROON; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SEROLOGY; VIRUS LOAD;

ADENINE; ADULT; AGE FACTORS; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; CAMEROON; COMORBIDITY; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOSPHONIC ACIDS; PREGNANCY; RETROSPECTIVE STUDIES; TRANSAMINASES;

EID: 72449188638     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00742.x     Document Type: Article

References (14)

1. Modi AA, Feld JJ. Viral hepatitis and HIV in Africa. AIDS Rev 2007, 9:25-39.
2. Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 2007, 7:402-409.
3. Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a tertiary hospital. J Med Virol 2009, 81:406-412.
4. Agwale SM, Tanimoto L, Womack C. Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes. J Clin Virol 2004, 31((Suppl 1)):3-6.
5. Laurent C, Kouanfack C, Koulla-Shiro S. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet 2004, 364:29-34.
6. Bourgeois A, Laurent C, Mougnutou R. Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon. Antivir Ther 2005, 10:335-341.
7. Rockstroh JK, Spengler U. HIV and hepatitis C virus co-infection. Lancet Infect Dis 2004, 4:437-444.
8. Rouet F, Chaix ML, Inwoley A. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: the ANRS 1236 Study. J Med Virol 2004, 74:34-40.
9. Burnett RJ, Ngobeni JM, Francois G. Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women. Int J STD AIDS 2007, 18:152-156.
10. Waddell RD, Magesa PM, Pallangyo KJ. Coinfection with HIV and HCV in a blood bank population in Dar es Salaam, Tanzania. J Clin Virol 2006, 36:237-238.
11. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006, 44((Suppl 1)):6-9.
12. Sulkowski MS. Viral hepatitis and HIV coinfection. J Hepatol 2008, 48:353-367.
13. Matthews GV, Bartholomeusz A, Locarnini S. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy. AIDS 2006, 20:863-870.
14. http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf, World Health Organization., Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access. Recommendations for a public health approach (2006 revision). Available at, (accessed 3 September 2008)